Selecting disease‐modifying medications in 5q spinal muscular atrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selecting disease‐modifying medications in 5q spinal muscular atrophy

Published:2021-07-07 Issue:4 Volume:64 Page:404-412
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle & Nerve

Author:

Cartwright Michael S.¹,Upadhya Suraj¹

Affiliation:

1. Department of Neurology Wake Forest School of Medicine Winston‐Salem North Carolina USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27358

Reference37 articles.

1. Identification and characterization of a spinal muscular atrophy-determining gene

2. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

3. The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation

4. Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular Atrophy

5. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical perspectives: Treating spinal muscular atrophy;Molecular Therapy;2024-08

2. Risdiplam Real World Data – Looking Beyond Motor Neurons and Motor Function Measures;Journal of Neuromuscular Diseases;2024-01-02

3. Evaluation of the therapeutic efficacy and tolerability of current drug treatments on the clinical outcomes of paediatric spinal muscular atrophy type 1: A systematic review;Paediatric Respiratory Reviews;2023-12

4. A case series evaluating patient perceptions after switching from nusinersen to risdiplam for spinal muscular atrophy;Muscle & Nerve;2023-12

5. Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region;Annals of Clinical and Experimental Neurology;2023-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3